| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines
|
Coughlin, Richard T.
|
|
1995
|
13 |
1 |
p. 17-21
5 p.
|
artikel
|
| 2 |
Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases
|
Harasawa, Ryô
|
|
1995
|
13 |
1 |
p. 100-103
4 p.
|
artikel
|
| 3 |
A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections
|
de la Maza, Michael A.
|
|
1995
|
13 |
1 |
p. 119-127
9 p.
|
artikel
|
| 4 |
An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses
|
Race, Esther
|
|
1995
|
13 |
1 |
p. 54-60
7 p.
|
artikel
|
| 5 |
Calendar
|
|
|
1995
|
13 |
1 |
p. 136-
1 p.
|
artikel
|
| 6 |
Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations
|
Stieneker, Frank
|
|
1995
|
13 |
1 |
p. 45-53
9 p.
|
artikel
|
| 7 |
Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components
|
Sacchi, Claudio Tavares
|
|
1995
|
13 |
1 |
p. 112-118
7 p.
|
artikel
|
| 8 |
Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants
|
Al-Shakhshir, Ragheb H.
|
|
1995
|
13 |
1 |
p. 41-44
4 p.
|
artikel
|
| 9 |
Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration
|
Asanuma, Hideki
|
|
1995
|
13 |
1 |
p. 3-5
3 p.
|
artikel
|
| 10 |
Does envelope V3 peptide comprise the principal neutralizing determinant for HIV?
|
Slobod, Karen S.
|
|
1995
|
13 |
1 |
p. 129-
1 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
1995
|
13 |
1 |
p. IFC-
1 p.
|
artikel
|
| 12 |
Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs
|
Bernstein, David I.
|
|
1995
|
13 |
1 |
p. 72-76
5 p.
|
artikel
|
| 13 |
Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen
|
Tamura, Mizuho
|
|
1995
|
13 |
1 |
p. 77-82
6 p.
|
artikel
|
| 14 |
Evaluation of a recombinant Schistosoma mansoni 28 kDa antigen for vaccination of zebu calves against S. bovis
|
Aradaib, Imadeldin E.
|
|
1995
|
13 |
1 |
p. 130-
1 p.
|
artikel
|
| 15 |
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children
|
Scheifele, David W.
|
|
1995
|
13 |
1 |
p. 104-108
5 p.
|
artikel
|
| 16 |
Flavivirus e.g. variola virus recombinant surface antigen protein production and expression using e.g. a vacconia virus vector; application as an attenuated recombinant vaccine
|
|
|
1995
|
13 |
1 |
p. 128-
1 p.
|
artikel
|
| 17 |
Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine
|
Cryz Jr, S.J.
|
|
1995
|
13 |
1 |
p. 67-71
5 p.
|
artikel
|
| 18 |
Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: A field trial
|
Elad, D.
|
|
1995
|
13 |
1 |
p. 83-87
5 p.
|
artikel
|
| 19 |
Modified recombinant virus; antitumour recombinant vaccine production with vaccinia virus or canarypox virus vector and tumour necrosis factor, tumour-associated antigen, interleukin, interferon gene, etc.
|
|
|
1995
|
13 |
1 |
p. 128-
1 p.
|
artikel
|
| 20 |
Nucleic acid vaccines
|
Spier, R.E.
|
|
1995
|
13 |
1 |
p. 131-132
2 p.
|
artikel
|
| 21 |
Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus
|
Romero, C.H.
|
|
1995
|
13 |
1 |
p. 36-40
5 p.
|
artikel
|
| 22 |
Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein
|
Sumner, John W.
|
|
1995
|
13 |
1 |
p. 29-35
7 p.
|
artikel
|
| 23 |
Recombinant vaccine composed of luminal antigen domain, cytoplasm endosome-lysosome targeting signal and a recombinant vaccinia virus vector; DNA sequence; potential cancer gene therapy
|
|
|
1995
|
13 |
1 |
p. 128-
1 p.
|
artikel
|
| 24 |
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates
|
Baqar, Shahida
|
|
1995
|
13 |
1 |
p. 22-28
7 p.
|
artikel
|
| 25 |
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers
|
Kärnell, Anders
|
|
1995
|
13 |
1 |
p. 88-99
12 p.
|
artikel
|
| 26 |
Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines
|
Coursaget, P.
|
|
1995
|
13 |
1 |
p. 109-111
3 p.
|
artikel
|
| 27 |
The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks
|
Russell, P.H.
|
|
1995
|
13 |
1 |
p. 61-66
6 p.
|
artikel
|
| 28 |
The sixth international conference on Lyme Borreliosis: Progress on the development of lyme disease vaccines
|
Edelman, Robert
|
|
1995
|
13 |
1 |
p. 133-135
3 p.
|
artikel
|
| 29 |
Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate
|
Roberts, J.A.
|
|
1995
|
13 |
1 |
p. 11-16
6 p.
|
artikel
|
| 30 |
Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults
|
McElhaney, Janet E.
|
|
1995
|
13 |
1 |
p. 6-10
5 p.
|
artikel
|
| 31 |
Yersinia enterocolitica and Yersinia pseudotuberculosis invasive structural gene inv expression in Escherichia coli using plasmid pBR322; application as a recombinant vaccine and in pathogen screening
|
|
|
1995
|
13 |
1 |
p. 128-
1 p.
|
artikel
|
Tijdschrift beschrijving